MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy

NCT05500612 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-05-19

No results posted yet for this study

Summary

This study is designed to evaluate the role of Oxygen Enhanced (OE) Magnetic resonance imaging (MRI) and Blood Oxygenation Level Dependent (BOLD) MRI in detecting regions of hypoxic tumour and to evaluate their use as imaging methods to selectively deliver targeted radiotherapy to regions of aggressive disease.

Conditions

Sponsors & Collaborators

  • The Brain Cancer Group

    collaborator UNKNOWN
  • University of Sydney

    lead OTHER

Principal Investigators

  • Caterina Brighi · University of Sydney

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-14
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05500612 on ClinicalTrials.gov